Canopy Growth Corp. Just Destroyed Over $1 Million of Weed: Time to Sell?

Canopy Growth Corp. (TSX:WEED) has destroyed over $1 million of medical marijuana produced by the company’s subsidiary Mettrum Ltd., which allegedly sprayed its cannabis plants with a banned chemical pesticide.

Canopy Growth Corp. (TSX: WEED) has been one of the best-performing stocks of 2016, but it may be starting to exhibit serious signs of slowing down after an announcement Tuesday that the company was forced to destroy over $1 million of medical marijuana that was recalled by Health Canada. The company has since written down approximately $800,000 of inventory relating to product sold in 2016.

The write-down

Canopy has destroyed over $1 million of medical marijuana produced by the company’s subsidiary Mettrum Ltd. which has allegedly sprayed its cannabis plants with banned chemical pesticide myclobutanil since 2014, according to a former Mettrum employee. This pesticide is prohibited because when heated, the pesticide emits hydrogen cyanide.

The former employee also indicated that not only did the company knowingly spray this prohibited pesticide on its plants, but it hid the pesticide in the ceiling tiles during Health Canada inspections to avoid detection; Health Canada was not testing plants for banned chemicals at the time.

An expensive acquisition

Canopy agreed to purchase Mettrum Ltd. in December and has been granted court approval to complete the acquisition earlier this month. This acquisition may prove to be a very expensive deal with industry experts suggesting the problem may be much larger than the $800,000 initial write-down as an unknown amount of product is affected.

At this time, Health Canada only requires periodic spot checks on cannabis produced by companies granted a license to produce cannabis by the Canadian government. Medical marijuana patients are now increasingly becoming worried about the cannabis products they consume given the risks associated with the banned pesticide and the unknown quantity of affected cannabis circulating in the marketplace today.

Because Canopy is licensed by the Canadian government and required to comply with Health Canada regulations, questions remain as to whether or not the company’s license to produce cannabis will be affected at any time in the future.

Potentially an industry-wide issue

Organigram Holdings Inc., another Canadian medical marijuana producer, has indicated that its write-downs relating to this recall have amounted to approximately $500,000. It appears that these recent announcements may only be the tip of the iceberg should Health Canada begin regular testing of cannabis for pesticides — something that medical marijuana patients would clearly like to see happen.

The Globe and Mail has reported that “patients of both companies have contacted The Globe in recent weeks describing symptoms that include persistent nausea, vomiting, and difficulty breathing. All are similar to the known symptoms of hydrogen-cyanide poisoning.”

At this point in time, it is clear that Canopy investors should be extremely careful considering the potential impact of additional write-downs and the implications this recall may have for the company’s production license in the future. Right now may be the time to take some money off the table.

Stay Foolish, my friends.

Fool contributor Chris MacDonald has no position in any stocks mentioned.

More on Investing

Engineers walk through a facility.
Stocks for Beginners

WSP vs. Stantec: Which Engineering Stock Would I Buy With $10,000?

WSP’s record backlog is tempting. I’d buy Stantec with my next $10,000 and keep WSP on the list while I…

Read more »

dividend stocks bring in passive income so investors can sit back and relax
Tech Stocks

Already Own Shopify? What the Sell-off Means for Your Investment

Analyze the seasonal trends of Shopify and understand what caused the recent stock dip after a significant rally.

Read more »

dumpsters sit outside for waste collection and trash removal
Dividend Stocks

2 TFSA Stocks to Consider With $7,000

Here’s why investing $7,000 in these two fundamentally strong Canadian stocks could help you build handsome tax-free wealth over the…

Read more »

telecom towers concept for wireless technology
Dividend Stocks

1 Dividend Stock to Buy and Hold for Decades

With its stable business, reliable cash flows, growth prospects, and strong dividend history, Fortis is an attractive long-term investment for…

Read more »

diversification is an important part of building a stable portfolio
Energy Stocks

How I’d Structure a $10,000 TFSA for Steady Income, Stock By Stock

Wondering how to earn over $325 per year in your TFSA? This simple 4-stock portfolio bulks up in some of…

Read more »

hiker with backpack in the mountains
Dividend Stocks

Retirement Income: Top Canadian Stocks That Keep Paying Out

Explore top Canadian stocks that keep paying out, with Enbridge, BMO and Granite REIT offering dividend income and monthly distributions

Read more »

moving into apartment
Dividend Stocks

2 of the Best Canadian Stocks to Buy and Hold in a TFSA

These two fundamentally strong Canadian stocks could help TFSA investors build long-term wealth through business growth, dividends, and potential capital…

Read more »

a person watches a downward arrow crash through the floor
Dividend Stocks

TSX Dips Nearly 736 Points: 3 Canadian Dividend Stocks to Hold Through the Noise

Steep market drops won’t rattle investors owning three quality Canadian dividend stocks.

Read more »